LabGenius was founded by Dr James Field in 2012, with Synthetic Biology leaders Professor Paul Freemont and Professor Richard Kitney also part of the founding team. In 2014, backing from both private investors and the UK government enabled the company to develop, validate and commercialise their novel DNA library synthesis technology. With this patent-pending technology, LabGenius is able to construct DNA libraries that are more diverse, accurate, and flexible than any other on the market.
LabGenius also leverages its core technology in a number of major industrial collaborations. This has allowed the company to develop expertise in a range of protein engineering projects ranging from improving antibodies to creating novel biomaterials.